b Tested in sodium chloride 0.9%.
c Test performed using the formulation WITHOUT edetate disodium.
d Tested in sodium chloride 0.45%.
e Tested in both dextrose 5% and sodium chloride 0.9%.
f Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.
g Tested in Ringer’s injection, lactated.
h Tested in sterile water for injection.
i Tested in dextrose 5% in Ringer’s injection, lactated.
j Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
k Tested in Haemaccel (Behring).
l Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.
m Not specified whether concentration refers to single component or combined components.
n Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
o Quinupristin and dalfopristin components combined.
p Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
q Test performed using the formulation WITH edetate disodium.
r Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.